Zobrazeno 1 - 10
of 453
pro vyhledávání: '"John A. Lust"'
Autor:
Patrick W. Mellors, Surendra Dasari, Mindy C. Kohlhagen, Taxiarchis Kourelis, Ronald S. Go, Eli Muchtar, Morie A. Gertz, Shaji K. Kumar, Francis. K. Buadi, Maria A. V. Willrich, John A. Lust, Prashant Kapoor, Martha Q. Lacy, David Dingli, Yi Hwa, Amie Fonder, Miriam Hobbs, Susan Hayman, Rahma Warsame, Nelson R. Leung, Yi Lin, Wilson Gonsalves, Mustaqeem Siddiqui, Robert A. Kyle, S. Vincent Rajkumar, David L. Murray, Angela Dispenzieri
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-9 (2021)
Abstract Immunoenrichment-based matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS), termed MASS-FIX, offers several advantages over immunofixation for the detection and isotyping of serum monoclonal protein, i
Externí odkaz:
https://doaj.org/article/bd967d6555a44353ab1424735729b9af
Autor:
Alissa Visram, Abdullah S. Al Saleh, Harsh Parmar, Jennifer S. McDonald, John C. Lieske, Iuliana Vaxman, Eli Muchtar, Miriam Hobbs, Amie Fonder, Yi L. Hwa, Francis K. Buadi, David Dingli, Martha Q. Lacy, Angela Dispenzieri, Prashant Kapoor, Suzanne R. Hayman, Rahma Warsame, Taxiarchis V. Kourelis, Mustaqeem Siddiqui, Wilson I. Gonsalves, John A. Lust, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz, Shaji K. Kumar, Nelson Leung
Publikováno v:
Blood Cancer Journal, Vol 10, Iss 12, Pp 1-8 (2020)
Abstract A 24-h urine protein collection (24hUP), the gold standard for measuring albuminuria in systemic AL amyloidosis, is cumbersome and inaccurate. We retrospectively reviewed 575 patients with systemic AL amyloidosis to assess the correlation be
Externí odkaz:
https://doaj.org/article/0c3021aea92f4413819ef8b208d47004
Autor:
Arjun Lakshman, Utkarsh Painuly, S. Vincent Rajkumar, Rhett P. Ketterling, Prashant Kapoor, Patricia T. Greipp, Angela Dispenzieri, Morie A. Gertz, Francis K. Buadi, Martha Q. Lacy, David Dingli, Amie L. Fonder, Suzanne R. Hayman, Miriam A. Hobbs, Wilson I. Gonsalves, Yi Lisa Hwa, Nelson Leung, Ronald S. Go, Yi Lin, Taxiarchis V. Kourelis, Rahma Warsame, John A. Lust, Stephen J. Russell, Steven R. Zeldenrust, Robert A. Kyle, Shaji K. Kumar
Publikováno v:
Blood Advances, Vol 3, Iss 13, Pp 1930-1938 (2019)
Abstract: The high-risk abnormality del(17p) can be detected by fluorescence in situ hybridization on malignant plasma cells (PCs) and has an adverse prognostic impact in patients with multiple myeloma (MM). Patients with del(17p) have reduced overal
Externí odkaz:
https://doaj.org/article/a708625245944f65affeb4fc31fd1ac8
Autor:
Patrick W. Mellors, Surendra Dasari, Mindy C. Kohlhagen, Taxiarchis Kourelis, Ronald S. Go, Eli Muchtar, Morie A. Gertz, Shaji K. Kumar, Francis. K. Buadi, Maria A. V. Willrich, John A. Lust, Prashant Kapoor, Martha Q. Lacy, David Dingli, Yi Hwa, Amie Fonder, Miriam Hobbs, Susan Hayman, Rahma Warsame, Nelson R. Leung, Yi Lin, Wilson Gonsalves, Mustaqeem Siddiqui, Robert A. Kyle, S. Vincent Rajkumar, David L. Murray, Angela Dispenzieri
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-2 (2021)
Externí odkaz:
https://doaj.org/article/b71841d0495e4e9aaf162a59bcaf5c7c
Autor:
Eli Muchtar, Angela Dispenzieri, Shaji K. Kumar, David Dingli, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Rajshekhar Chakraborty, Stephen Russell, John A. Lust, Yi Lin, Ronald S. Go, Steven Zeldenrust, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz
Publikováno v:
Haematologica, Vol 101, Iss 9 (2016)
Clinical tools to guide in the appropriate treatment selection in immunoglobulin light chain (AL) amyloidosis are not well developed. We evaluated the response and outcome for various regimens at first-line treatment (n=681) and first progression (n=
Externí odkaz:
https://doaj.org/article/3c6730eba31040a285bfabd2e2e74baa
Autor:
Nelson Leung, Siobhan V. Glavey, Shaji Kumar, Angela Dispenzieri, Francis K. Buadi, David Dingli, Martha Q. Lacy, Suzanne R. Hayman, John A. Lust, Stephen J. Russell, Steven R. Zeldenrust, S. Vincent Rajkumar, Morie A. Gertz
Publikováno v:
Haematologica, Vol 98, Iss 6 (2013)
Organ response correlates with overall survival in patients with immunoglobulin light chain amyloidosis and is the goal of treatment. This study evaluates the current renal response criteria and their ability to predict overall survival. Patients wit
Externí odkaz:
https://doaj.org/article/ce991b6ac9da40e4a85703f510c7d28d
Autor:
Alan H. Bryce, Rhett P. Ketterling, Morie A. Gertz, Martha Lacy, Ryan A. Knudson, Steven Zeldenrust, Shaji Kumar, Suzanne Hayman, Francis Buadi, Robert A. Kyle, Philip R. Greipp, John A. Lust, Stephen Russell, S. Vincent Rajkumar, Rafael Fonseca, Angela Dispenzieri
Publikováno v:
Haematologica, Vol 94, Iss 3 (2009)
Background Light chain amyloidosis is a rare plasma cell dyscrasia. Interphase fluorescence in situ hybridization (FISH) coupled to cytoplasmic staining of specific Ig (cIg-FISH) on bone marrow plasma cells has become well established in the initial
Externí odkaz:
https://doaj.org/article/1c48693fb3b446a3b86541be2e8e94dd
Autor:
Morie A. Gertz, Martha Q. Lacy, John A. Lust, Philip R. Greipp, Thomas E. Witzig, Robert A. Kyle
Publikováno v:
Haematologica, Vol 93, Iss 9 (2008)
Survival of patients with plasma cell disorders has increased. However, the expanding use of melphalan in patients with longer survival suggests that myelodysplasia may become increasingly important. The objective of this study was to determine the r
Externí odkaz:
https://doaj.org/article/1372842b104d4eaeb1ec7b5c71d95864
Autor:
Surendra Dasari, Mindy C. Kohlhagen, Angela Dispenzieri, Maria A.V. Willrich, Melissa R. Snyder, Taxiarchis V. Kourelis, John A. Lust, John R. Mills, Robert A. Kyle, David L. Murray
Publikováno v:
Mayo Clinic Proceedings. 97:294-307
To verify the analytical performance of a new mass spectrometry-based method, termed MASS-FIX, when screening for plasma cell disorders in a routine clinical laboratory.Results from 19,523 unique patients tested for an M-protein between July 24, 2018
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b23466a6f5924ee35dc2d06a5053d7ae
https://doi.org/10.1016/j.mayocp.2021.07.024
https://doi.org/10.1016/j.mayocp.2021.07.024
Autor:
Stephen M. Broski, Shaji Kumar, John A. Lust, David Dingli, Ronald S. Go, Miriam Hobbs, Suzanne R. Hayman, Prashant Kapoor, Rahma Warsame, Francis K. Buadi, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Lisa Hwa, Vincent Rajkumar, Taxiarchis Kourelis, Wilson I. Gonsalves, Yi Lin, Nelson Leung, Marcella Kaddoura, Amie Fonder, Robert A. Kyle
Publikováno v:
Blood Adv
Multiple myeloma (MM) is a heterogeneous disease that may be evaluated by a broad array of imaging and laboratory techniques to measure disease activity and predict prognosis. Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26b4750cea08666d243aad498b0f5d8b
https://doi.org/10.1182/bloodadvances.2020004131
https://doi.org/10.1182/bloodadvances.2020004131